Mitochondria and the Actin Cytoskeleton in Neurodegeneration
Cytoskeleton · 2026-04 · 83 (4) · 200-210
DOI: 10.1002/cm.70095 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cytoskeleton, online erschienen am 08.01.2026. Verfasst von Shivani Tuli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Mitochondria, Actin Cytoskeleton, Neurodegenerative Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Mitochondrial dysfunction and cytoskeletal disorganization are widely recognized hallmarks of neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS). Although these disorders differ in clinical presentation and etiology, accumulating evidence points to a shared cellular vulnerability at the intersection of mitochondrial dynamics and actin cytoskeletal regulation. In this review, we examine the emerging role of actin–mitochondria crosstalk as a convergent mechanism in neurodegeneration. We discuss how disruptions in actin filament remodeling, mitochondrial fission and fusion, organelle transport, and mitophagy contribute to neuronal dysfunction and loss across these diseases. Particular attention is given to disease‐specific pathways, including cofilin‐actin rod formation in AD, α‐synuclein–driven actin disruption in PD, mutant huntingtin's effects on mitochondrial fragmentation in HD, and profilin‐1–associated mitochondrial defects in ALS. By synthesizing findings from diverse models, we highlight how perturbations in the cytoskeleton–mitochondria interface may act as an upstream trigger and amplifier of neurodegenerative cascades. We also outline key knowledge gaps and propose future directions for research, with an emphasis on targeting actin–mitochondrial interactions as a potential therapeutic strategy across multiple neurodegenerative conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Media Arts and Sciences, MIT, Cambridge, Massachusetts, USA.
- Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Shivani Tuli, Preet Patel, Aneri Shethji, David Gau
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Tuli, S., Patel, P., Shethji, A., & Gau, D. (2026). Mitochondria and the Actin Cytoskeleton in Neurodegeneration. Cytoskeleton, 83(4), 200-210. https://doi.org/10.1002/cm.70095
Vancouver
Tuli S, Patel P, Shethji A, Gau D. Mitochondria and the Actin Cytoskeleton in Neurodegeneration. Cytoskeleton. 2026;83(4):200-210. doi:10.1002/cm.70095
BibTeX
@article{Tuli2026,
author = {Tuli, Shivani and Patel, Preet and Shethji, Aneri and Gau, David},
title = {Mitochondria and the Actin Cytoskeleton in Neurodegeneration},
journal = {Cytoskeleton},
year = {2026},
volume = {83},
number = {4},
pages = {200--210},
doi = {10.1002/cm.70095}
}
EUVIMED